| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 272.85 mm | 272.85 mm | 272.85 mm | 272.85 mm | 272.85 mm | 272.85 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 20.05 mm | 19.52 mm | 13.50 mm | 15.42 mm |
| Cash used (since last report) | n/a | n/a | 46.20 mm | 44.99 mm | 31.12 mm | 35.54 mm |
| Cash remaining | n/a | n/a | 226.65 mm | 227.86 mm | 241.73 mm | 237.31 mm |
| Runway (months of cash) | n/a | n/a | 11.3 | 11.7 | 17.9 | 15.4 |
| 13F holders | Current |
|---|---|
| Total holders | 123 |
| Opened positions | 32 |
| Closed positions | 28 |
| Increased positions | 37 |
| Reduced positions | 35 |
| 13F shares | Current |
|---|---|
| Total value | 479.54 bn |
| Total shares | 60.11 mm |
| Total puts | 2.06 mm |
| Total calls | 41.40 k |
| Total put/call ratio | 49.8 |
| Largest owners | Shares | Value |
|---|---|---|
| T. Rowe Price Investment Management | 5.50 mm | $58.41 mm |
| Redmile | 4.83 mm | $51.27 bn |
| BlackRock | 4.12 mm | $43.81 bn |
| FMR | 3.92 mm | $41.62 bn |
| EcoR1 Capital | 3.88 mm | $41.20 bn |
| Enavate Sciences GP | 3.48 mm | $36.94 bn |
| Immunome Aggregator | 3.48 mm | $28.52 mm |
| JHG Janus Henderson | 3.46 mm | $36.73 bn |
| Vanguard | 3.00 mm | $31.90 bn |
| MorphImmune | 2.66 mm | $20.48 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Sep 25 | Jack Higgins | Common Stock | Option exercise | Acquire M | No | No | 1.35 | 22,000 | 29.70 k | 40,729 |
| 10 Sep 25 | Jack Higgins | Employee Stock option Common Stock | Option exercise | Dispose M | No | No | 1.35 | 22,000 | 29.70 k | 151,840 |
| 29 Jul 25 | Sandra G. Stoneman | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 10.6 | 190,000 | 2.01 mm | 190,000 |
| 29 Jul 25 | Siegall Clay B | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 10.6 | 800,000 | 8.48 mm | 800,000 |
| 29 Jul 25 | Jack Higgins | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 10.6 | 196,000 | 2.08 mm | 196,000 |
| 29 Jul 25 | Kinney Horn | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 10.6 | 161,000 | 1.71 mm | 161,000 |
